Viewing Study NCT00412061


Ignite Creation Date: 2025-12-24 @ 1:02 PM
Ignite Modification Date: 2026-01-22 @ 6:43 AM
Study NCT ID: NCT00412061
Status: COMPLETED
Last Update Posted: 2014-11-21
First Post: 2006-12-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoid Tumor View
None Malignant Carcinoid Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Carcinoid View
None Tumor View
None Neuroendocrine View
None Carcinoma View
None Everolimus View
None Octreotide View